Hot Life Science Investor Mandate 3: Global PE Firm Seeking Healthcare IT and Wearable Device Opportunities

22 Jan

A global private equity firm headquartered in Geneva, Switzerland, with additional offices in Hong Kong, New York, London, and Cairo is currently seeking new opportunities. The firm is backed by two family offices and employs a co-investment strategy. The firm currently has USD 330 million AUM and invests across a spectrum of private equity strategies including leading and/or participating in direct investments in the angel/seed, growth, and buyout stages. The firm typically invests up to USD 100K at the angel stage and USD 5-15 million for growth and buyout stages. The firm takes an active minority position without its growth strategy investments. The firm invests in companies based in the US, EU, and Middle East. The firm is actively seeking new investment opportunities.

In Healthcare, the firm is currently interested in HCIT companies and to a lesser degree medical technology. Devices such as wearable devices with a major software component are of interest. The firm does not generally invest in Class II and III devices. The firm may be interested in services or technology companies that are related to biotechnology.

The firm seeks a strong and entrepreneurial management team and typically requires board representation in its portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: